SCHEMBL26071086

SCHEMBL26071086

Cc1noc(-c2ccccc2)c1COc1cccc(-c2nn[nH]c2N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.40
BRD4 O60885 2/20 0.38
BRD2 P25440 1/20 0.38
CREBBP Q92793 1/20 0.38
GABRA5 P31644 1/20 0.37
LMNA P02545 4/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 2/20 0.37
POLB P06746 2/20 0.36
TP53 P04637 1/20 0.36
ALDH1A1 P00352 5/20 0.36
IGF1R P08069 1/20 0.36
MEN1 O00255 2/20 0.35
TSHR P16473 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18006436 0.86 ALOX15 (0.40) SLC22A12BRD4BRD2CREBBPGABRA5
SCHEMBL4639164 0.81 MAOB (0.50) BRD4BRD2CREBBPGABRA5LMNA
SCHEMBL26071067 0.80 PTGER4 (0.40) SLC22A12MAPTSMN1; SMN2HPGDPOLB
SCHEMBL26071016 0.79 SLC22A12 (0.38) SLC22A12BRD4BRD2CREBBPMAPT
SCHEMBL26071083 0.74 SLC22A12 (0.38) SLC22A12MAPTSMN1; SMN2HPGDPOLB
SCHEMBL4639160 0.74 ALDH1A1 (0.53) LMNAMAPTSMN1; SMN2HPGDPOLB
SCHEMBL18006394 0.74 ALDH1A1 (0.50) BRD4BRD2CREBBPGABRA5LMNA
SCHEMBL26071018 0.74 NOTUM (0.38) SLC22A12MAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL26071092 0.73 IGF1R (0.39) SLC22A12MAPTALDH1A1IGF1RMEN1
SCHEMBL18006212 0.73 GABRA5 (0.36) BRD4GABRA5SMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 EP disclosed